206 related articles for article (PubMed ID: 9765509)
41. Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.
Bunch RT; Eastman A
Clin Cancer Res; 1996 May; 2(5):791-7. PubMed ID: 9816232
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors.
Hunáková L; Suliková M; Duraj J; Sedlák J; Chorváth B
Neoplasma; 1996; 43(5):291-5. PubMed ID: 8996546
[TBL] [Abstract][Full Text] [Related]
43. Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.
Harvey S; Decker R; Dai Y; Schaefer G; Tang L; Kramer L; Dent P; Grant S
Clin Cancer Res; 2001 Feb; 7(2):320-30. PubMed ID: 11234887
[TBL] [Abstract][Full Text] [Related]
44. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).
Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S
Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490
[TBL] [Abstract][Full Text] [Related]
45. Multiple effects of staurosporine, a kinase inhibitor, on thymocyte functions. Comparison with the effect of tyrosine kinase inhibitors.
Zilberman Y; Gutman Y
Biochem Pharmacol; 1992 Oct; 44(8):1563-8. PubMed ID: 1417980
[TBL] [Abstract][Full Text] [Related]
46. UCN-01 Kyowa Hakko Kogyo Co.
Grosios K
Curr Opin Investig Drugs; 2001 Feb; 2(2):287-97. PubMed ID: 11816846
[TBL] [Abstract][Full Text] [Related]
47. UCN-01 (7-hydroxystaurosporine) induces apoptosis and G1 arrest of both primary and metastatic oral cancer cell lines in vitro.
Otsubo A; Bhawal UK; Nomura Y; Mitani Y; Ozawa K; Kuniyasu H; Sugiyama M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):391-7. PubMed ID: 17321452
[TBL] [Abstract][Full Text] [Related]
48. UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line.
Kawakami K; Futami H; Takahara J; Yamaguchi K
Biochem Biophys Res Commun; 1996 Feb; 219(3):778-83. PubMed ID: 8645257
[TBL] [Abstract][Full Text] [Related]
49. Involvement of protein kinase C-epsilon in glucocorticoid-induced apoptosis in thymocytes.
Iwata M; Iseki R; Sato K; Tozawa Y; Ohoka Y
Int Immunol; 1994 Mar; 6(3):431-8. PubMed ID: 8186194
[TBL] [Abstract][Full Text] [Related]
50. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
Hecker M; Preiss C; Schini-Kerth VB
Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
[TBL] [Abstract][Full Text] [Related]
51. UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily.
Mizuno K; Noda K; Ueda Y; Hanaki H; Saido TC; Ikuta T; Kuroki T; Tamaoki T; Hirai S; Osada S
FEBS Lett; 1995 Feb; 359(2-3):259-61. PubMed ID: 7867810
[TBL] [Abstract][Full Text] [Related]
52. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.
Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J
J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614
[TBL] [Abstract][Full Text] [Related]
53. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
Pollack IF; Kawecki S; Lazo JS
J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
[TBL] [Abstract][Full Text] [Related]
54. The release of microparticles by Jurkat leukemia T cells treated with staurosporine and related kinase inhibitors to induce apoptosis.
Ullal AJ; Pisetsky DS
Apoptosis; 2010 May; 15(5):586-96. PubMed ID: 20146001
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of chemotactic peptide-induced development of cell polarity and locomotion by the protein kinase C inhibitor CGP 41 251 in human neutrophils correlates with inhibition of protein phosphorylation.
Niggli V; Keller H
Exp Cell Res; 1993 Feb; 204(2):346-55. PubMed ID: 8440331
[TBL] [Abstract][Full Text] [Related]
56. UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century?
Akinaga S; Sugiyama K; Akiyama T
Anticancer Drug Des; 2000 Feb; 15(1):43-52. PubMed ID: 10888035
[TBL] [Abstract][Full Text] [Related]
57. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
Akinaga S; Gomi K; Morimoto M; Tamaoki T; Okabe M
Cancer Res; 1991 Sep; 51(18):4888-92. PubMed ID: 1893379
[TBL] [Abstract][Full Text] [Related]
58. DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.
MacFarlane M; Jones NA; Dive C; Cohen GM
Mol Pharmacol; 1996 Oct; 50(4):900-11. PubMed ID: 8863836
[TBL] [Abstract][Full Text] [Related]
59. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
60. Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cells.
Ikegami Y; Yano S; Nakao K
Arzneimittelforschung; 1996 Feb; 46(2):201-4. PubMed ID: 8720314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
